1. Home
  2. NYXH vs WALD Comparison

NYXH vs WALD Comparison

Compare NYXH & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

N/A

Current Price

$1.66

Market Cap

161.9M

Sector

Health Care

ML Signal

N/A

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.33

Market Cap

187.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYXH
WALD
Founded
2009
1988
Country
Belgium
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
187.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NYXH
WALD
Price
$1.66
$1.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$9.33
$2.00
AVG Volume (30 Days)
118.5K
305.3K
Earning Date
05-12-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$213.98
$9.89
Revenue Next Year
$126.25
$4.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.72
52 Week High
$6.87
$3.22

Technical Indicators

Market Signals
Indicator
NYXH
WALD
Relative Strength Index (RSI) 59.44 33.36
Support Level $1.28 $1.23
Resistance Level $1.70 $1.85
Average True Range (ATR) 0.07 0.10
MACD 0.04 -0.01
Stochastic Oscillator 96.20 4.90

Price Performance

Historical Comparison
NYXH
WALD

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: